A six‐gene‐based prognostic signature for hepatocellular carcinoma overall survival prediction

[1]  C. Desbois-Mouthon,et al.  Low Levels of Microsatellite Instability at Simple Repeated Sequences Commonly Occur in Human Hepatocellular Carcinoma. , 2017, Cancer genomics & proteomics.

[2]  Yang Zhao,et al.  Seven-CpG-based prognostic signature coupled with gene expression predicts survival of oral squamous cell carcinoma , 2017, Clinical Epigenetics.

[3]  S. Weatherbee,et al.  IFT56 regulates vertebrate developmental patterning by maintaining IFTB complex integrity and ciliary microtubule architecture , 2017, Development.

[4]  Yan Zhu,et al.  Prognostic Biomarker Identification Through Integrating the Gene Signatures of Hepatocellular Carcinoma Properties , 2017, EBioMedicine.

[5]  J. O’Shaughnessy,et al.  The hedgehog pathway in triple‐negative breast cancer , 2016, Cancer medicine.

[6]  R. Hong,et al.  Significance of the hedgehog pathway-associated proteins Gli-1 and Gli-2 and the epithelial-mesenchymal transition-associated proteins Twist and E-cadherin in hepatocellular carcinoma , 2016, Oncology letters.

[7]  K. Dimas,et al.  The Prognostic Significance of the Hedgehog Signaling Pathway in Colorectal Cancer. , 2016, Clinical colorectal cancer.

[8]  C. Mayr,et al.  Differential role of Hedgehog signaling in human pancreatic (patho-) physiology: An up to date review. , 2016, World journal of gastrointestinal pathophysiology.

[9]  Shun-Fa Yang,et al.  Effects of HMGB1 Polymorphisms on the Susceptibility and Progression of Hepatocellular Carcinoma , 2016, International journal of medical sciences.

[10]  Jae Min Lee,et al.  The management and prognosis of patients with hepatocellular carcinoma: what has changed in 20 years? , 2016, Liver international : official journal of the International Association for the Study of the Liver.

[11]  Fei Wang,et al.  BRD4 induces cell migration and invasion in HCC cells through MMP-2 and MMP-9 activation mediated by the Sonic hedgehog signaling pathway. , 2015, Oncology letters.

[12]  Tae Yong Kim,et al.  Negative Expression of CPSF2 Predicts a Poorer Clinical Outcome in Patients with Papillary Thyroid Carcinoma. , 2015, Thyroid : official journal of the American Thyroid Association.

[13]  A. Fiorelli,et al.  SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer , 2015, Clinical Cancer Research.

[14]  Fei Wang,et al.  BRD 4 induces cell migration and invasion in HCC cells through MMP ‐ 2 and MMP ‐ 9 activation mediated by the Sonic hedgehog signaling pathway , 2015 .

[15]  M. Kumar,et al.  Role of supportive care for terminal stage hepatocellular carcinoma. , 2014, Journal of clinical and experimental hepatology.

[16]  H. Ling,et al.  MicroRNAs, Genomic Instability and Cancer , 2014, International journal of molecular sciences.

[17]  The radiologist as interpreter and translator. , 2014, Radiology.

[18]  G. Malaguarnera,et al.  Hepatocellular Carcinoma: Novel Molecular Targets in Carcinogenesis for Future Therapies , 2014, BioMed research international.

[19]  C. Bortner,et al.  Ion channels and apoptosis in cancer , 2014, Philosophical Transactions of the Royal Society B: Biological Sciences.

[20]  M. Kudo,et al.  Unique Association between Global DNA Hypomethylation and Chromosomal Alterations in Human Hepatocellular Carcinoma , 2013, PloS one.

[21]  Lin Li,et al.  Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma , 2013, Genome research.

[22]  Wangjun Wu,et al.  Overexpression of Six1 gene suppresses proliferation and enhances expression of fast-type muscle genes in C2C12 myoblasts , 2013, Molecular and Cellular Biochemistry.

[23]  K. Vousden,et al.  p53 mutations in cancer , 2013, Nature Cell Biology.

[24]  Amy L. Olex,et al.  Microarray analysis reveals age-related differences in gene expression during the development of osteoarthritis in mice. , 2012, Arthritis and rheumatism.

[25]  R. Lencioni,et al.  Local-regional treatment of hepatocellular carcinoma. , 2012, Radiology.

[26]  J. Bruix,et al.  Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects , 2010, Seminars in liver disease.

[27]  Y. Ishikawa,et al.  Sarcalumenin is essential for maintaining cardiac function during endurance exercise training. , 2009, American journal of physiology. Heart and circulatory physiology.

[28]  J. Bruix,et al.  Major achievements in hepatocellular carcinoma , 2009, The Lancet.

[29]  J. Marrero,et al.  Diagnosis and treatment of hepatocellular carcinoma. , 2008, Gastroenterology.

[30]  L. Pardo,et al.  Eag1: an emerging oncological target. , 2008, Cancer research.

[31]  I. Boros,et al.  TATA binding protein associated factor 3 (TAF3) interacts with p53 and inhibits its function , 2008, BMC Molecular Biology.

[32]  S. Olivier,et al.  Voltage-gated ion channels, new targets in anti-cancer research. , 2007 .

[33]  J. Le Guennec,et al.  Voltage-gated ion channels, new targets in anti-cancer research. , 2007, Recent patents on anti-cancer drug discovery.

[34]  R. Sikes,et al.  Voltage-sensitive ion channels and cancer , 2006, Cancer and Metastasis Reviews.

[35]  J. Sicklick,et al.  Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis. , 2006, Carcinogenesis.

[36]  Francesco Donato,et al.  Hepatocellular carcinoma in cirrhosis: incidence and risk factors. , 2004, Gastroenterology.

[37]  Nick Proudfoot,et al.  New perspectives on connecting messenger RNA 3' end formation to transcription. , 2004, Current opinion in cell biology.

[38]  W. Schunack,et al.  [Action of partially cyclic and ring methylated nikethamide analogs. Structure-activity relationships of analeptics of the nicethamide type]. , 1977, Arzneimittel-Forschung.